BioDuro and Cenra launch joint venture to expand resilient global API manufacturing capacity: Irvine Californa Thursday, March 5, 2026, 14:00 Hrs [IST] BioDuro, a globally trusted ...
Luxna Biotech & Inabata ink license agreement for manufacture and sale of modified nucleic acid GuNA amidite: Osaka, Japan Monday, March 16, 2026, 09:00 Hrs [IST] Luxna Biotech Co ...
The CDMO’s Module 1 commercial production facility to be operational by summer 2026 Hyderabad, March 9th 2026: Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 ...
Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic ...
With the healthcare landscape continually evolving, the generic medicines industry guarantees widespread access to affordable medications for millions of patients worldwide. Generics play a pivotal ...
Crystalline nanomaterials are valuable because their highly ordered structures give them useful properties for technologies ...
Key market opportunities for organometallics include expanding applications in advanced electronics, semiconductors, and ...
Pharmaceutical Technology on MSN
AbbVie announces $380M investment in North Chicago API facilities
Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results